International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Diclofenac Sodium 1%-15% Topical Gel

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2022 - Volume 26, Number 1
View All Articles in Issue

Page(s): 55

Diclofenac Sodium 1%-15% Topical Gel Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Diclofenac Sodium 1%-15% Topical Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, diclofenac sodium, topical preparations, inflammation, nonsteroidal anti-inflammatory drug, NSAID, phenylacetic acid derivative, inflammatory diseases, fever, antipyretic agent, actinic keratosis

Related Categories: FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Diclofenac Sodium 1%-15% Topical Gel Allen Loyd V Jr	Jan/Feb 2022 Pg. 55
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Basics of Compounding for Cold Sores or Fever Blisters Allen Loyd V Jr	May/Jun 2004 Pg. 206-209
Diclofenac Sodium 1% Topical Gel Allen Loyd V Jr	May/Jun 2011 Pg. 243
Diclofenac Sodium 1% Soft-Patch Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 65
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Allen Loyd V Jr	Jan/Feb 2008 Pg. 66
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin	Sep/Oct 2015 Pg. 357-365
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution Allen Loyd V Jr	Jan/Feb 2010 Pg. 74
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 540
Diclofenac Sodium 10-mg/mL Oral Suspension Allen Loyd V Jr	Jan/Feb 2011 Pg. 64
Diclofenac Sodium 75-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2007 Pg. 421
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Allen Loyd V Jr	Sep/Oct 2022 Pg. 430
Chemical Stability of Diclofenac Sodium Injection Gupta Vishnu D	Mar/Apr 2006 Pg. 154-155
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Zur Eyal	Sep/Oct 2012 Pg. 386-393
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA	Mar/Apr 2016 Pg. 167-174
Return to Top